Effects of repeated oral methamphetamine administration in humans
- PMID: 11441429
- DOI: 10.1007/s002130100727
Effects of repeated oral methamphetamine administration in humans
Abstract
Rationale: Although methamphetamine use has increased over the past several years, few studies have evaluated the effects of repeated methamphetamine administration in humans.
Objectives: Because methamphetamine is often taken in a pattern of repeated use followed by a period of abstinence, the present study sought to evaluate the effects of repeated methamphetamine administration in humans. The hypothesis was that tolerance would develop to methamphetamine's effects.
Methods: Seven normal, healthy volunteers participated in a 15-day residential study. Participants completed subjective-effects questionnaires and psychomotor performance tasks repeatedly throughout the experimental day. Oral methamphetamine (5, 10 mg BID) was administered on days 4-6 and 10-12; placebo was administered on all other study days.
Results: Relative to placebo baseline, only two "positive" subjective ratings ("I feel a good drug effect" and "I feel high") were significantly elevated, and only on the 1st day of methamphetamine administration. In contrast, numerous "negative" ratings, including "I feel..." "a bad drug effect," "dizzy," and "flu-like symptoms" were elevated on the 3rd day of methamphetamine administration. Total caloric intake decreased and sleep was disrupted after methamphetamine administration, relative to baseline.
Conclusions: The pattern of methamphetamine's positive subjective effects were altered with chronic administration such that tolerance, or a decreased effect, occurred after repeated administration. In contrast, methamphetamine's negative subjective effects increased over days. These results suggest that in this population of normal volunteers, the abuse liability of oral methamphetamine is relatively low.
Similar articles
-
Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work.Psychopharmacology (Berl). 2003 Aug;169(1):42-51. doi: 10.1007/s00213-003-1464-4. Epub 2003 May 7. Psychopharmacology (Berl). 2003. PMID: 12734635 Clinical Trial.
-
Methamphetamine self-administration by humans.Psychopharmacology (Berl). 2001 Aug;157(1):75-81. doi: 10.1007/s002130100738. Psychopharmacology (Berl). 2001. PMID: 11512046
-
Acute physiological and behavioral effects of intranasal methamphetamine in humans.Neuropsychopharmacology. 2008 Jul;33(8):1847-55. doi: 10.1038/sj.npp.1301578. Epub 2007 Sep 12. Neuropsychopharmacology. 2008. PMID: 17851535 Free PMC article. Clinical Trial.
-
Methamphetamine and the expanding complications of amphetamines.West J Med. 1999 Apr;170(4):214-9. West J Med. 1999. PMID: 10344175 Free PMC article. Review.
-
[Establishment and evaluation of animal model with methamphetamine poisoning].Fa Yi Xue Za Zhi. 2009 Aug;25(4):282-5. Fa Yi Xue Za Zhi. 2009. PMID: 19788080 Review. Chinese.
Cited by
-
Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech.Psychopharmacology (Berl). 2010 Feb;208(2):169-77. doi: 10.1007/s00213-009-1715-0. Epub 2009 Nov 17. Psychopharmacology (Berl). 2010. PMID: 19916063 Clinical Trial.
-
Effects of acute methamphetamine on emotional memory formation in humans: encoding vs consolidation.PLoS One. 2015 Feb 13;10(2):e0117062. doi: 10.1371/journal.pone.0117062. eCollection 2015. PLoS One. 2015. PMID: 25679982 Free PMC article.
-
Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans.Psychopharmacology (Berl). 2012 Jan;219(1):191-204. doi: 10.1007/s00213-011-2390-5. Epub 2011 Jul 12. Psychopharmacology (Berl). 2012. PMID: 21748253 Free PMC article.
-
Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?CNS Drugs. 2020 May;34(5):449-461. doi: 10.1007/s40263-020-00722-8. CNS Drugs. 2020. PMID: 32248427 Free PMC article. Review.
-
Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeys.Psychopharmacology (Berl). 2017 Aug;234(15):2277-2287. doi: 10.1007/s00213-017-4654-1. Epub 2017 Jun 7. Psychopharmacology (Berl). 2017. PMID: 28589263 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous